Ph.D. Director Project Management

In April 2001, Dr. Snel joined Kinesis as a Senior Consultant on non-clinical drug development. In this position, he has organized and monitored a wide range of toxicity, ADME and PK/TK studies at contract research facilities on behalf of sponsoring companies. Dr. Snel has written numerous reports, and contributed to the non-clinical sections of a large number of IMPDs, CTDs, INDs and IBs. Where needed, the activities were performed at the R&D facilities of the sponsoring companies. In July 2006, Dr. Snel joined the Kinesis Project Management group and assumed responsibility for the management of the non-clinical part of several drug development projects.

Prior to his affiliation with Kinesis, Dr. Snel headed the In Vivo Biotransformation group at Johnson & Johnson Pharmaceuticals, Beerse, Belgium (1997-2001), and he was responsible for the safety assessment of detergent ingredients at Procter & Gamble, Strombeek-Bever, Belgium (1994-1997). He completed his Ph.D. research in 1994 on a drug metabolism-related collaborative project of the Universities of Leiden, The Netherlands and Toronto, Canada. Dr. Snel obtained a M.Sc. degree in Bio-Pharmaceutical Sciences from Leiden University in 1990 and a B.Sc. degree in clinical chemistry and hematology in 1984.